NCT00298285View on ClinicalTrials.gov

ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2006

Conditions
Mechanical Valve ReplacementWarfarin Therapy
Interventions
DRUG

enoxaparin

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00298285 - ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement | Biotech Hunter | Biotech Hunter